Cellular and molecular aspects of vascular dysfunction in systemic sclerosis

Area of Science:

• Vascular Biology
• Immunology
• Fibrosis Research

Background:

• Systemic sclerosis (SSc) presents with vascular alterations, immune activation, and fibrosis.
• Early vascular insufficiency in SSc is marked by capillary deterioration despite repair attempts.
• Potential causes include persistent injury, mediator imbalance, cellular abnormalities, and antiangiogenic factors.

Purpose of the Study:

• To elucidate the molecular and cellular mechanisms underlying systemic sclerosis vasculopathy.
• To identify key factors contributing to the failure of vascular regeneration in SSc.
• To provide a foundation for developing targeted therapies for SSc vascular disease.

Main Methods:

• Analysis of vascular alterations in Systemic Sclerosis.
• Investigation of immune system activation and tissue fibrosis.
• Examination of proangiogenic and antiangiogenic mediator balance.
• Assessment of endothelial progenitor cell function and transcription factor expression (Fra2, Fli1).

Main Results:

• Vascular insufficiency and capillary regression are key features of SSc.
• Dysfunctional endothelial progenitor cells and abnormal transcription factor expression (e.g., reduced Fli1) may contribute to SSc vasculopathy.
• Endothelial cells and pericytes may transdifferentiate into collagen-producing cells, initiating fibrosis.

Conclusions:

• The precise molecular and cellular pathways driving SSc vasculopathy are not fully understood.
• Reduced Fli1 levels may lead to unstable vasculature prone to regression in SSc.
• Further research into these pathways is essential for advancing SSc treatment strategies.